How much funding has PIC Therapeutics raised?

PIC Therapeutics has raised $40.0M in total funding, most recently a Series A round.

Who are PIC Therapeutics's investors?

PIC Therapeutics's investors include OrbiMed, Lumira Ventures, Advent Life Sciences.

Where is PIC Therapeutics headquartered?

PIC Therapeutics is headquartered in Natick, Massachusetts, United States.

What industry is PIC Therapeutics in?

PIC Therapeutics operates in Biotech, Healthcare.

How many employees does PIC Therapeutics have?

PIC Therapeutics has 11-50 employees.

PIC Therapeutics

Natick, United States · $40.0M raised

Biotech

Healthcare

Headquarters: Natick, Massachusetts
Employees: 11–50
Business Model: B2B
Website: pictherapeutics.com

Total Funding: $40.0M
Last Round: $35.0M Series AOct 2022
Rounds: 2

About

PIC Therapeutics is a Natick, Massachusetts-based biopharmaceutical company pioneering the discovery and development of first-in-mechanism, first-in-class small molecule medicines that modulate protein translation to treat cancer. The company targets the Pre-Initiation Complex (PIC), a master switch in oncogenic signaling pathways, to selectively reduce production of cancer-driving proteins while sparing normal cells. Its lead program is an allosteric modulator of eIF4E advancing toward clinical trials in advanced metastatic breast cancer. The approach is designed to address both drug resistance and tumor heterogeneity that plague existing cancer treatments.

Summary

PIC Therapeutics is a Biotech company based in Natick, United States. It has raised $40.0M in total across 2 rounds, most recently a $35.0M Series A round in Oct 2022. Investors include OrbiMed, Lumira Ventures and Advent Life Sciences.